The future growth potential of EKSO BIONICS HOLDING (OTCBB:EKSO), a robotic exoskeleton company, solidified after a gunshot victim was awarded a fully remunerated Ekso GT suit by a High Court in the United Kingdom. Reportedly, Dale Messenger, who suffered a gunshot wound and was left paralyzed by a spinal cord injury, has been ordered compensation in the long running legal case.
As per the compensation, Messenger will be reimbursed for the full purchase cost of EKSO BIONICS HOLDING (OTCBB:EKSO)’s GT robotic exoskeleton as well as the expenses incurred for its replacement and utilization over the next several years. In the published note, Messenger said that the court reviewed the company’s exoskeleton and compared it with other similar products. However, Ekso’s exoskeleton proved to be of better value. Messenger said that exoskeleton has relieved him of a number of health related issues such as pain, bladder or bowel function.
Meanwhile, the law firm, Stewarts Law LLP, which was overseeing the case said that this is the first time when a court in the United Kingdom has issued order for the reimbursement of cost associated with a home rehabilitation device as well as other utilization costs. EKSO BIONICS HOLDING (OTCBB:EKSO)’s CEO, Nathan Harding called the decision as a breakthrough achievement for individuals, who wish to improve rehabilitation facilities at their home. Moreover, Harding is optimistic that the data being collected at the Europe’s top rehabilitation centers would evidence that how the company’s exoskeleton is better in many ways. Harding sees the chances of more legal settlements allowing patients access to the company’s rehabilitation suit.
EKSO BIONICS HOLDING (OTCBB:EKSO) exoskeleton is a wearable suit that let any individuals suffering from any extremity to walk or stand on the ground. The stock of the company rose by 5.04% to $1.46 during the last trading session, when the average volume was reported at 422,478 shares.